acrolein has been researched along with Diabetic Glomerulosclerosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YP; Cheng, HW; Kuo, CW; Lin, CC; Liu, WS; Lu, SH; Tong, ZJ; Tsai, MT; Tsou, HH; Wang, HT; Yen, PC | 1 |
| Liang, XC; Liu, D; Sun, Y; Wu, YN; Zhang, H | 1 |
| Tian, GX; Wu, YT; Xia, CQ; Yao, L; Zhang, F; Zhang, W | 1 |
| Bhatti, R; Mishra, A; Singh Ishar, MP; Singh, A | 1 |
| Chang, WT; Chao, LK; Huang, JS; Shih, YW | 1 |
| de Haan, JB | 1 |
| Fang, D; Whitman, SA; Wondrak, GT; Wong, PK; Wu, W; Zhang, DD; Zheng, H | 1 |
| Alvares-Aguilar, C; Medina-Navarro, R; Nieto-Aguilar, R | 1 |
| Abe, M; Hisano, S; Horiuchi, S; Iwasaki, H; Nangaku, M; Sakata, N; Uesugi, N | 1 |
| Fukagawa, M; Hamada, Y | 1 |
10 other study(ies) available for acrolein and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Acrolein plays a culprit role in the pathogenesis of diabetic nephropathy in vitro and in vivo.
Topics: Acetylcysteine; Acrolein; Animals; Carnosine; Cytokines; Diabetes Mellitus; Diabetic Nephropathies; Environmental Pollutants; HEK293 Cells; Humans; Hydralazine; Kidney; Mice; Streptozocin | 2022 |
Combination of Quercetin, Hirudin and Cinnamaldehyde Promotes Schwann Cell Differentiation and Myelination against High Glucose by Inhibiting ERK Signaling Pathway.
Topics: Acrolein; Animals; Cells, Cultured; Diabetic Nephropathies; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Glucose; Hirudins; Myelin Sheath; Quercetin; Rats; Rats, Sprague-Dawley; Schwann Cells | 2020 |
Acrolein Scavenger Hydralazine Prevents Streptozotocin-Induced Painful Diabetic Neuropathy and Spinal Neuroinflammation in Rats.
Topics: Acrolein; Animals; Diabetic Nephropathies; Drug Evaluation, Preclinical; Hydralazine; Male; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Streptozocin; Vasodilator Agents | 2017 |
Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy.
Topics: Acrolein; Animals; Blood Glucose; Catalase; Cholesterol; Cinnamomum zeylanicum; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Glutathione; Hypoglycemic Agents; Kidney; Lipoproteins, HDL; Male; Oils, Volatile; Plant Oils; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Urea | 2010 |
Cinnamaldehyde impairs high glucose-induced hypertrophy in renal interstitial fibroblasts.
Topics: Acrolein; Diabetic Nephropathies; Fibroblasts; Glucose; Humans; Hypertrophy; Kidney; MAP Kinase Signaling System; Nephritis, Interstitial | 2010 |
Nrf2 activators as attractive therapeutics for diabetic nephropathy.
Topics: Acrolein; Animals; Diabetic Nephropathies; Humans; Isothiocyanates; NF-E2-Related Factor 2; Sulfoxides; Thiocyanates | 2011 |
Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy.
Topics: Acrolein; Animals; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Diabetic Nephropathies; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Humans; Isothiocyanates; Kidney; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Random Allocation; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sulfoxides; Thiocyanates; Transforming Growth Factor beta1 | 2011 |
Protein conjugated with aldehydes derived from lipid peroxidation as an independent parameter of the carbonyl stress in the kidney damage.
Topics: Acrolein; Aldehydes; Animals; Blood Proteins; Case-Control Studies; Diabetic Nephropathies; Humans; Kinetics; Lipid Peroxidation; Liver; Male; Microsomes; NADP; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Reference Standards; Serum Albumin; Spectrophotometry | 2011 |
Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.
Topics: Acrolein; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Complement Activation; Complement Membrane Attack Complex; Diabetic Nephropathies; Female; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Humans; Hypertension; Kidney; Kidney Glomerulus; Lysine; Male; Middle Aged; Models, Biological; Nephrosclerosis; Oxidation-Reduction; Tunica Media | 2004 |
A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acrolein; Albuminuria; Animals; Biomarkers; Carrier Proteins; Collagen Type IV; Deoxyguanosine; Diabetic Nephropathies; Hypertrophy; Kidney; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; RNA, Messenger; Streptozocin; Thioredoxins; Transforming Growth Factor beta | 2007 |